CLINICAL_TRIALS
trial_result
· 2010-01-06
Clinical Trial Update: Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma [Phase 2]
Summary
Phase 2 trial of pazopanib in relapsed or refractory soft tissue sarcoma has completed and results were posted in January 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Sarcoma, Soft Tissue | Phase 2 | Status: COMPLETED | Results posted: 2010-01-06